Incyte Corporation INCY NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

82/100

6/7 Pass

SharesGrow Intrinsic Value

Incyte Corporation (INCY) has 20 détenteurs institutionnels et initiés connus enregistrés. Le plus grand détenteur est BAKER FELIX avec 2,944,621 actions. Parmi les autres détenteurs notables BAKER BROS. ADVISORS LP et Hoppenot Herve.

Au cours des 12 derniers mois, les initiés ont effectué 69 transactions sur INCY l'action — 27 achats (d'une valeur de $12.93M) et 15 ventes (d'une valeur de $31.59M). Les achats d'initiés ont dépassé les ventes durant cette période, ce qui peut signaler une confiance dans les perspectives de l'entreprise.

INCY Participations des Initiés

Principal Actionnaire

BAKER FELIX

2,944,621 actions

Achats (12 mois)

$12.93M valeur

Ventes (12 mois)

$31.59M valeur

Activité de transactions (12 mois)

Acheter 39%

Vendre 22%

Principaux actionnaires initiés

#	Nom	Rôle	Actions détenues	Dernière déclaration	Taille relative
1	Baker Felix	Director	2,944,621	2022-10-04	100%
2	Baker Bros. Advisors Lp	10 Percent Owner	2,818,039	2026-04-02	96%
3	Hoppenot Herve	Director	326,803	2025-12-10	11%
4	Stamoulis Christiana	EVP & Chief Financial Officer	110,123	2025-04-03	4%
5	Swain Paula J	EVP, Human Resources	96,362	2025-04-03	3%
6	Flannelly Barry P	EVP & General Manager Us	44,726	2025-04-03	2%
7	Iyengar Vijay K	EVP, Gmapps	41,817	2025-04-03	1%
8	Heeson Lee	EVP, Head of Incyte Intl	38,041	2026-02-04	1%
9	Dickinson Jonathan Elliott	EVP, General Manager, Europe	36,390	2024-09-16	1%
10	Morrissey Michael James	EVP, Head of Tech. Operations	34,065	2026-02-04	1%
11	Clancy Paul J	Director	23,741	2026-04-02	1%
12	Harrigan Edmund	Director	21,122	2026-04-02	1%
13	Pasquale Maria E	EVP & General Counsel	20,275	2023-07-18	1%
14	Stein Steven H	EVP & Chief Medical Officer	19,932	2026-01-21	1%
15	Dixon Wendy L	Director	17,768	2022-04-04	1%
16	Dhanak Dashyant	EVP & Chief Scientific Officer	16,896	2023-07-18	1%
17	Wenqing Yao	EVP, Head of Discovery Chem	15,054	2021-07-07	1%
18	Trotta Matteo	EVP, GM, Dermatology Us	14,882	2026-03-26	1%
19	Issa Mohamed Khairie	EVP, Head of Us Oncology	14,237	2026-01-21	0%
20	Friedman Paul A	Director	10,514	2020-05-28	0%

Transactions récentes (12 derniers mois)

Date	Nom	Rôle	Type	Actions	Prix	Valeur
2026-03-31	Clancy Paul J	Director	Attribution de RSU	265	$94.12	$24.94K
2026-03-31	Baker Bros. Advisors Lp	10 Percent Owner	Attribution de RSU	421	-	-
2026-03-31	Harrigan Edmund	Director	Attribution de RSU	269	$94.12	$25.32K
2026-03-25	Trotta Matteo	EVP, GM, Dermatology Us	Retenue Fiscale RSU	537	$92.23	$49.53K
2026-03-17	Cagnoni Pablo J	President, R&d	Exercice d'Options (Vente)	7,166	$61.18	$438.42K
2026-02-19	Cagnoni Pablo J	President, R&d	Exercice d'Options (Vente)	13,093	$61.76	$808.62K
2026-02-02	Heeson Lee	EVP, Head of Incyte Intl	Retenue Fiscale RSU	111	$102.67	$11.4K
2026-02-02	Morrissey Michael James	EVP, Head of Tech. Operations	Retenue Fiscale RSU	185	$102.67	$18.99K
2026-01-16	Mayes Patrick A	EVP & Chief Scientific Officer	Attribution de RSU	4,218	$106.21	$447.99K
2026-01-16	Issa Mohamed Khairie	EVP, Head of Us Oncology	Attribution de RSU	14,237	$106.21	$1.51M
2026-01-16	Heeson Lee	EVP, Head of Incyte Intl	Attribution de RSU	8,911	-	-
2026-01-16	Trotta Matteo	EVP, GM, Dermatology Us	Attribution de RSU	8,542	$106.21	$907.25K
2026-01-16	Tray Thomas	Principal Accounting Officer	Attribution de RSU	2,425	$106.21	$257.56K
2026-01-20	Morrissey Michael James	EVP, Head of Tech. Operations	Retenue Fiscale RSU	429	$102.62	$44.02K
2026-01-16	Morrissey Michael James	EVP, Head of Tech. Operations	Attribution de RSU	7,426	-	-
2026-01-16	Stein Steven H	EVP & Chief Medical Officer	Attribution de RSU	19,932	$106.21	$2.12M
2026-01-16	Cagnoni Pablo J	President, R&d	Attribution de RSU	28,475	$106.21	$3.02M
2026-01-07	Issa Mohamed Khairie	EVP, Head of Us Oncology	Vente Informative	10,856	$109.07	$1.18M
2026-01-06	Issa Mohamed Khairie	EVP, Head of Us Oncology	Retenue Fiscale RSU	8,264	$106.66	$881.44K
2026-01-05	Stein Steven H	EVP & Chief Medical Officer	Vente Informative	15,634	$101.70	$1.59M
2025-12-31	Morrissey Michael James	EVP, Head of Tech. Operations	Retenue Fiscale RSU	254	$98.77	$25.09K
2025-12-31	Stein Steven H	EVP & Chief Medical Officer	Retenue Fiscale RSU	13,292	$98.77	$1.31M
2025-12-31	Clancy Paul J	Director	Attribution de RSU	241	$98.77	$23.8K
2025-12-31	Baker Bros. Advisors Lp	10 Percent Owner	Attribution de RSU	328	-	-
2025-12-31	Harrigan Edmund	Director	Attribution de RSU	245	$98.77	$24.2K